Anne Libby
Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 12 | 2024 | 475 | 1.500 |
Why?
| | Mental Health Services | 12 | 2016 | 478 | 1.390 |
Why?
| | Financing, Organized | 4 | 2020 | 36 | 1.210 |
Why?
| | Research Personnel | 5 | 2020 | 187 | 1.050 |
Why?
| | Comparative Effectiveness Research | 4 | 2013 | 170 | 0.960 |
Why?
| | Indians, North American | 6 | 2008 | 567 | 0.890 |
Why?
| | Nonprescription Drugs | 3 | 2016 | 69 | 0.810 |
Why?
| | Substance-Related Disorders | 8 | 2008 | 1112 | 0.750 |
Why?
| | Biomedical Research | 5 | 2020 | 723 | 0.750 |
Why?
| | Antidepressive Agents | 6 | 2015 | 245 | 0.740 |
Why?
| | Managed Care Programs | 10 | 2011 | 140 | 0.740 |
Why?
| | Sex Factors | 8 | 2025 | 2136 | 0.700 |
Why?
| | Depressive Disorder | 6 | 2015 | 379 | 0.690 |
Why?
| | Faculty, Medical | 4 | 2022 | 308 | 0.660 |
Why?
| | Mentoring | 3 | 2022 | 166 | 0.650 |
Why?
| | Capitation Fee | 5 | 2002 | 14 | 0.630 |
Why?
| | Interdisciplinary Research | 1 | 2020 | 26 | 0.620 |
Why?
| | Mental Disorders | 5 | 2017 | 1188 | 0.580 |
Why?
| | Sex Characteristics | 3 | 2022 | 799 | 0.550 |
Why?
| | United States Food and Drug Administration | 4 | 2009 | 208 | 0.540 |
Why?
| | Antihypertensive Agents | 4 | 2025 | 522 | 0.530 |
Why?
| | Emergency Services, Psychiatric | 1 | 2017 | 31 | 0.520 |
Why?
| | Child Welfare | 4 | 2007 | 233 | 0.500 |
Why?
| | Pharmacists | 2 | 2024 | 259 | 0.500 |
Why?
| | Interdisciplinary Studies | 1 | 2016 | 30 | 0.490 |
Why?
| | Writing | 1 | 2018 | 101 | 0.490 |
Why?
| | Academic Medical Centers | 3 | 2020 | 566 | 0.480 |
Why?
| | Prescription Drugs | 2 | 2016 | 111 | 0.480 |
Why?
| | Academies and Institutes | 1 | 2016 | 61 | 0.470 |
Why?
| | Mentors | 5 | 2022 | 218 | 0.460 |
Why?
| | Child Abuse | 6 | 2008 | 558 | 0.450 |
Why?
| | Science | 1 | 2016 | 55 | 0.450 |
Why?
| | Contract Services | 3 | 2002 | 11 | 0.450 |
Why?
| | United States | 31 | 2025 | 16313 | 0.430 |
Why?
| | Fee-for-Service Plans | 5 | 2002 | 99 | 0.430 |
Why?
| | Health Policy | 5 | 2016 | 405 | 0.420 |
Why?
| | Colorado | 17 | 2020 | 4591 | 0.420 |
Why?
| | Quality-Adjusted Life Years | 3 | 2014 | 126 | 0.420 |
Why?
| | Child Abuse, Sexual | 3 | 2007 | 81 | 0.420 |
Why?
| | Juvenile Delinquency | 3 | 2004 | 95 | 0.410 |
Why?
| | Health Care Costs | 2 | 2010 | 428 | 0.400 |
Why?
| | Dibenzothiazepines | 1 | 2013 | 18 | 0.400 |
Why?
| | Medication Therapy Management | 1 | 2014 | 73 | 0.390 |
Why?
| | Data Collection | 5 | 2012 | 652 | 0.390 |
Why?
| | Cooperative Behavior | 1 | 2016 | 471 | 0.380 |
Why?
| | Humans | 77 | 2025 | 147306 | 0.380 |
Why?
| | Videoconferencing | 2 | 2017 | 65 | 0.370 |
Why?
| | Telemedicine | 2 | 2024 | 978 | 0.370 |
Why?
| | Length of Stay | 2 | 2017 | 1371 | 0.370 |
Why?
| | Adolescent | 33 | 2017 | 22826 | 0.360 |
Why?
| | Cohort Studies | 13 | 2016 | 6099 | 0.360 |
Why?
| | Male | 49 | 2025 | 73954 | 0.360 |
Why?
| | Physicians | 4 | 2022 | 961 | 0.350 |
Why?
| | Suicide, Attempted | 3 | 2015 | 430 | 0.350 |
Why?
| | Female | 51 | 2025 | 80081 | 0.340 |
Why?
| | Cities | 1 | 2012 | 140 | 0.340 |
Why?
| | Antipsychotic Agents | 1 | 2013 | 211 | 0.340 |
Why?
| | Income | 1 | 2012 | 208 | 0.340 |
Why?
| | Unemployment | 1 | 2010 | 43 | 0.320 |
Why?
| | Plant Preparations | 1 | 2010 | 37 | 0.310 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1379 | 0.310 |
Why?
| | Research Support as Topic | 3 | 2020 | 83 | 0.310 |
Why?
| | Cost of Illness | 1 | 2012 | 327 | 0.310 |
Why?
| | Tobacco Smoke Pollution | 1 | 2012 | 227 | 0.300 |
Why?
| | Depression | 3 | 2014 | 1599 | 0.290 |
Why?
| | Prescriptions | 1 | 2009 | 75 | 0.290 |
Why?
| | Cost-Benefit Analysis | 6 | 2017 | 654 | 0.290 |
Why?
| | Polypharmacy | 2 | 2024 | 95 | 0.290 |
Why?
| | Hypertension | 3 | 2025 | 1280 | 0.280 |
Why?
| | Multivariate Analysis | 6 | 2017 | 1550 | 0.280 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 6011 | 0.270 |
Why?
| | Point-of-Care Systems | 1 | 2010 | 189 | 0.270 |
Why?
| | Child, Preschool | 14 | 2017 | 12017 | 0.270 |
Why?
| | Health Maintenance Organizations | 2 | 2005 | 105 | 0.260 |
Why?
| | Child | 24 | 2017 | 22980 | 0.260 |
Why?
| | Middle Aged | 29 | 2025 | 36821 | 0.260 |
Why?
| | Premature Birth | 1 | 2012 | 390 | 0.260 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2007 | 902 | 0.260 |
Why?
| | Epilepsy | 1 | 2012 | 399 | 0.260 |
Why?
| | Chronic Disease | 2 | 2013 | 1845 | 0.260 |
Why?
| | Drug and Narcotic Control | 1 | 2007 | 24 | 0.250 |
Why?
| | Combat Disorders | 1 | 2007 | 42 | 0.250 |
Why?
| | Interview, Psychological | 1 | 2007 | 95 | 0.250 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2009 | 185 | 0.250 |
Why?
| | Research Design | 3 | 2019 | 1158 | 0.240 |
Why?
| | Education, Medical | 2 | 2020 | 277 | 0.240 |
Why?
| | Parents | 3 | 2017 | 1428 | 0.240 |
Why?
| | Health Services Accessibility | 3 | 2007 | 1122 | 0.240 |
Why?
| | Health Behavior | 1 | 2012 | 799 | 0.230 |
Why?
| | Longitudinal Studies | 8 | 2016 | 3029 | 0.230 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1107 | 0.220 |
Why?
| | Adult | 26 | 2025 | 41406 | 0.220 |
Why?
| | Decision Making | 1 | 2013 | 994 | 0.220 |
Why?
| | Hypoglycemia | 1 | 2010 | 489 | 0.220 |
Why?
| | Retrospective Studies | 13 | 2025 | 17561 | 0.210 |
Why?
| | Smoking | 1 | 2012 | 1483 | 0.210 |
Why?
| | Aged | 20 | 2025 | 26516 | 0.210 |
Why?
| | Stress, Psychological | 2 | 2010 | 1174 | 0.210 |
Why?
| | Aged, 80 and over | 9 | 2024 | 8432 | 0.210 |
Why?
| | Family | 2 | 2006 | 690 | 0.200 |
Why?
| | Parenting | 1 | 2008 | 320 | 0.200 |
Why?
| | Crime | 1 | 2004 | 58 | 0.200 |
Why?
| | Curriculum | 3 | 2020 | 1083 | 0.200 |
Why?
| | Ambulatory Care | 4 | 2014 | 625 | 0.200 |
Why?
| | Rural Population | 2 | 2007 | 685 | 0.200 |
Why?
| | Deprescriptions | 1 | 2024 | 38 | 0.190 |
Why?
| | Suicide | 3 | 2007 | 737 | 0.190 |
Why?
| | Primary Health Care | 4 | 2024 | 1760 | 0.170 |
Why?
| | Residential Treatment | 1 | 2002 | 30 | 0.170 |
Why?
| | Adolescent Psychiatry | 1 | 2002 | 15 | 0.170 |
Why?
| | Brain Injuries | 2 | 2005 | 508 | 0.170 |
Why?
| | Foster Home Care | 1 | 2003 | 88 | 0.170 |
Why?
| | Anxiety Disorders | 1 | 2005 | 376 | 0.170 |
Why?
| | Criminal Law | 1 | 2002 | 31 | 0.170 |
Why?
| | Child Psychiatry | 1 | 2002 | 36 | 0.170 |
Why?
| | Contracts | 1 | 2001 | 11 | 0.170 |
Why?
| | Logistic Models | 6 | 2017 | 2142 | 0.170 |
Why?
| | Electronic Health Records | 3 | 2015 | 1214 | 0.170 |
Why?
| | Blood Pressure | 2 | 2025 | 1785 | 0.170 |
Why?
| | Costs and Cost Analysis | 3 | 2010 | 221 | 0.170 |
Why?
| | Infant | 9 | 2017 | 10195 | 0.170 |
Why?
| | Schizophrenia | 1 | 2005 | 489 | 0.170 |
Why?
| | Health Surveys | 3 | 2010 | 522 | 0.170 |
Why?
| | Hospitals, Pediatric | 2 | 2017 | 571 | 0.160 |
Why?
| | Surface Plasmon Resonance | 1 | 2021 | 87 | 0.160 |
Why?
| | Severity of Illness Index | 6 | 2014 | 2974 | 0.160 |
Why?
| | Women's Health | 2 | 2020 | 317 | 0.160 |
Why?
| | Organizational Innovation | 2 | 2020 | 119 | 0.160 |
Why?
| | Hypoglycemic Agents | 1 | 2010 | 1415 | 0.160 |
Why?
| | Education | 1 | 2020 | 106 | 0.150 |
Why?
| | Dried Blood Spot Testing | 1 | 2021 | 129 | 0.150 |
Why?
| | Population Groups | 3 | 2017 | 56 | 0.150 |
Why?
| | Organophosphates | 1 | 2021 | 179 | 0.150 |
Why?
| | Dementia | 1 | 2024 | 332 | 0.150 |
Why?
| | Young Adult | 10 | 2017 | 14437 | 0.150 |
Why?
| | Interdisciplinary Communication | 1 | 2020 | 201 | 0.140 |
Why?
| | Health Services Research | 3 | 2016 | 392 | 0.140 |
Why?
| | Caregivers | 3 | 2024 | 1091 | 0.140 |
Why?
| | Adenine | 1 | 2021 | 339 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 741 | 0.140 |
Why?
| | Foundations | 1 | 2018 | 27 | 0.130 |
Why?
| | Gender Identity | 1 | 2019 | 133 | 0.130 |
Why?
| | Program Evaluation | 5 | 2021 | 952 | 0.130 |
Why?
| | Suicidal Ideation | 2 | 2015 | 590 | 0.130 |
Why?
| | Attitude to Health | 2 | 2017 | 431 | 0.130 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 528 | 0.130 |
Why?
| | Program Development | 1 | 2019 | 369 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2013 | 2030 | 0.130 |
Why?
| | Hospital Costs | 2 | 2012 | 130 | 0.130 |
Why?
| | Sexism | 1 | 2018 | 70 | 0.130 |
Why?
| | Hospitalization | 2 | 2011 | 2496 | 0.120 |
Why?
| | Public Health Administration | 1 | 1997 | 70 | 0.120 |
Why?
| | Reminder Systems | 1 | 2017 | 148 | 0.120 |
Why?
| | Immunization | 1 | 2017 | 375 | 0.110 |
Why?
| | Leadership | 1 | 2020 | 409 | 0.110 |
Why?
| | Risk Factors | 8 | 2012 | 11017 | 0.110 |
Why?
| | Alcoholism | 1 | 2002 | 838 | 0.110 |
Why?
| | Veterans | 1 | 2007 | 1675 | 0.110 |
Why?
| | Florida | 2 | 2025 | 118 | 0.100 |
Why?
| | Community Mental Health Services | 2 | 2007 | 85 | 0.100 |
Why?
| | Comorbidity | 3 | 2015 | 1672 | 0.100 |
Why?
| | Accidents | 2 | 2005 | 46 | 0.100 |
Why?
| | Quetiapine Fumarate | 1 | 2013 | 26 | 0.100 |
Why?
| | Oregon | 1 | 2013 | 83 | 0.100 |
Why?
| | Health Information Management | 1 | 2013 | 7 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 430 | 0.100 |
Why?
| | Alcohol-Related Disorders | 2 | 2005 | 126 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2017 | 718 | 0.090 |
Why?
| | Health Expenditures | 2 | 2006 | 199 | 0.090 |
Why?
| | Minority Groups | 2 | 2022 | 286 | 0.090 |
Why?
| | Analysis of Variance | 2 | 2014 | 1302 | 0.090 |
Why?
| | Medical Audit | 1 | 2013 | 77 | 0.090 |
Why?
| | Age Factors | 5 | 2012 | 3372 | 0.090 |
Why?
| | Regression Analysis | 3 | 2011 | 1003 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 742 | 0.090 |
Why?
| | Medical Records Systems, Computerized | 1 | 2013 | 96 | 0.090 |
Why?
| | Women's Health Services | 2 | 2006 | 15 | 0.090 |
Why?
| | Decision Support Techniques | 2 | 2014 | 480 | 0.090 |
Why?
| | Economics, Pharmaceutical | 1 | 2012 | 10 | 0.090 |
Why?
| | Education, Pharmacy, Graduate | 1 | 2012 | 13 | 0.090 |
Why?
| | Interviews as Topic | 2 | 2020 | 932 | 0.090 |
Why?
| | Diagnostic Tests, Routine | 1 | 2013 | 107 | 0.090 |
Why?
| | Efficiency | 1 | 2012 | 103 | 0.090 |
Why?
| | Education, Graduate | 1 | 2012 | 35 | 0.090 |
Why?
| | Maternal Age | 1 | 2012 | 129 | 0.090 |
Why?
| | Health Services | 1 | 2012 | 113 | 0.090 |
Why?
| | Prevalence | 3 | 2011 | 2889 | 0.090 |
Why?
| | Self Care | 1 | 2014 | 395 | 0.090 |
Why?
| | Pilot Projects | 2 | 2024 | 1912 | 0.090 |
Why?
| | Advisory Committees | 3 | 2007 | 233 | 0.080 |
Why?
| | Hospitals, University | 1 | 2012 | 176 | 0.080 |
Why?
| | Patient-Centered Care | 1 | 2016 | 552 | 0.080 |
Why?
| | State Health Plans | 2 | 2002 | 28 | 0.080 |
Why?
| | Nausea | 1 | 2011 | 112 | 0.080 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 69 | 0.080 |
Why?
| | Interinstitutional Relations | 1 | 2011 | 56 | 0.080 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2012 | 98 | 0.080 |
Why?
| | Infant, Small for Gestational Age | 1 | 2012 | 118 | 0.080 |
Why?
| | Vomiting | 1 | 2011 | 131 | 0.080 |
Why?
| | Referral and Consultation | 1 | 2017 | 886 | 0.080 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2012 | 89 | 0.080 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2011 | 75 | 0.080 |
Why?
| | Policy Making | 1 | 2011 | 83 | 0.080 |
Why?
| | Drug Labeling | 2 | 2007 | 37 | 0.080 |
Why?
| | Headache | 1 | 2011 | 151 | 0.080 |
Why?
| | Employment | 1 | 2012 | 184 | 0.080 |
Why?
| | Radiography, Interventional | 1 | 2012 | 128 | 0.080 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2011 | 103 | 0.080 |
Why?
| | Computer Communication Networks | 1 | 2010 | 32 | 0.080 |
Why?
| | Medication Adherence | 1 | 2014 | 540 | 0.080 |
Why?
| | Medicare | 3 | 2024 | 915 | 0.080 |
Why?
| | Social Support | 2 | 2020 | 655 | 0.080 |
Why?
| | Heart Transplantation | 1 | 2016 | 682 | 0.080 |
Why?
| | Influenza, Human | 2 | 2017 | 634 | 0.070 |
Why?
| | Proportional Hazards Models | 3 | 2015 | 1344 | 0.070 |
Why?
| | California | 3 | 2007 | 477 | 0.070 |
Why?
| | Life Style | 1 | 2012 | 504 | 0.070 |
Why?
| | Drug Utilization Review | 1 | 2009 | 61 | 0.070 |
Why?
| | Vaccination | 1 | 2017 | 1443 | 0.070 |
Why?
| | Information Dissemination | 1 | 2011 | 227 | 0.070 |
Why?
| | Residence Characteristics | 1 | 2012 | 387 | 0.070 |
Why?
| | Financing, Government | 2 | 2000 | 53 | 0.070 |
Why?
| | Community-Institutional Relations | 1 | 2009 | 101 | 0.070 |
Why?
| | Drug Prescriptions | 2 | 2007 | 293 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2012 | 379 | 0.070 |
Why?
| | Surveys and Questionnaires | 4 | 2020 | 6164 | 0.070 |
Why?
| | Absorptiometry, Photon | 1 | 2009 | 277 | 0.070 |
Why?
| | Catheter Ablation | 1 | 2012 | 360 | 0.070 |
Why?
| | Prospective Studies | 3 | 2021 | 8166 | 0.060 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2007 | 46 | 0.060 |
Why?
| | Office Visits | 1 | 2007 | 93 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 789 | 0.060 |
Why?
| | HIV Infections | 2 | 2021 | 3235 | 0.060 |
Why?
| | Trauma Severity Indices | 2 | 2005 | 117 | 0.060 |
Why?
| | Databases, Factual | 4 | 2016 | 1504 | 0.060 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 232 | 0.060 |
Why?
| | Drug Utilization | 1 | 2007 | 171 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2012 | 6543 | 0.060 |
Why?
| | Physicians, Family | 1 | 2007 | 179 | 0.060 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 2005 | 40 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2012 | 787 | 0.050 |
Why?
| | Cost Savings | 2 | 2012 | 86 | 0.050 |
Why?
| | Parent-Child Relations | 1 | 2008 | 272 | 0.050 |
Why?
| | Bone Density | 1 | 2009 | 493 | 0.050 |
Why?
| | Alcohol Drinking | 1 | 2012 | 858 | 0.050 |
Why?
| | Sleep | 1 | 2011 | 895 | 0.050 |
Why?
| | Psychiatry | 1 | 2007 | 197 | 0.050 |
Why?
| | Pregnancy | 2 | 2020 | 7276 | 0.050 |
Why?
| | Northwestern United States | 1 | 2004 | 58 | 0.050 |
Why?
| | Southwestern United States | 1 | 2004 | 93 | 0.050 |
Why?
| | Brain Damage, Chronic | 1 | 2003 | 18 | 0.050 |
Why?
| | Direct Service Costs | 1 | 2003 | 9 | 0.050 |
Why?
| | Volition | 1 | 2003 | 34 | 0.050 |
Why?
| | Age of Onset | 1 | 2005 | 568 | 0.050 |
Why?
| | Tobacco Use Disorder | 1 | 2005 | 217 | 0.050 |
Why?
| | Odds Ratio | 2 | 2004 | 1084 | 0.050 |
Why?
| | Monte Carlo Method | 2 | 2014 | 148 | 0.050 |
Why?
| | Sampling Studies | 1 | 2003 | 98 | 0.050 |
Why?
| | Somatoform Disorders | 1 | 2003 | 34 | 0.050 |
Why?
| | Quality of Life | 1 | 2015 | 3246 | 0.050 |
Why?
| | Marijuana Abuse | 1 | 2005 | 215 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 2007 | 594 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2013 | 11947 | 0.050 |
Why?
| | Rehabilitation, Vocational | 1 | 2002 | 6 | 0.040 |
Why?
| | Cost Allocation | 1 | 2002 | 7 | 0.040 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 116 | 0.040 |
Why?
| | Factor Analysis, Statistical | 1 | 2003 | 296 | 0.040 |
Why?
| | Calcium Channel Blockers | 1 | 2022 | 166 | 0.040 |
Why?
| | Child Health Services | 2 | 2001 | 191 | 0.040 |
Why?
| | Reimbursement, Incentive | 1 | 2002 | 42 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2009 | 3660 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 230 | 0.040 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2022 | 252 | 0.040 |
Why?
| | Practice Management, Medical | 1 | 2001 | 25 | 0.040 |
Why?
| | Immunity | 1 | 2022 | 141 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2002 | 330 | 0.040 |
Why?
| | Data Interpretation, Statistical | 1 | 2003 | 369 | 0.040 |
Why?
| | Qualitative Research | 2 | 2020 | 1735 | 0.040 |
Why?
| | Emergency Medical Services | 1 | 2007 | 691 | 0.040 |
Why?
| | Adolescent Behavior | 1 | 2005 | 498 | 0.040 |
Why?
| | Occupational Diseases | 1 | 2002 | 165 | 0.040 |
Why?
| | International Classification of Diseases | 2 | 2015 | 151 | 0.040 |
Why?
| | Incidence | 2 | 2005 | 2954 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 1147 | 0.040 |
Why?
| | Pediatrics | 1 | 2007 | 1139 | 0.030 |
Why?
| | Models, Statistical | 1 | 2003 | 677 | 0.030 |
Why?
| | Health Care Surveys | 2 | 1997 | 538 | 0.030 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 91 | 0.030 |
Why?
| | Risk Assessment | 3 | 2015 | 3784 | 0.030 |
Why?
| | Social Stigma | 1 | 2020 | 177 | 0.030 |
Why?
| | Competitive Bidding | 1 | 1997 | 3 | 0.030 |
Why?
| | Career Choice | 1 | 2019 | 237 | 0.030 |
Why?
| | Administrative Personnel | 1 | 1997 | 33 | 0.030 |
Why?
| | Decision Making, Organizational | 1 | 1997 | 24 | 0.030 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 106 | 0.030 |
Why?
| | Pneumococcal Vaccines | 1 | 2017 | 130 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3952 | 0.030 |
Why?
| | Specialization | 2 | 2007 | 137 | 0.030 |
Why?
| | Motivation | 1 | 2001 | 616 | 0.030 |
Why?
| | National Institute of Mental Health (U.S.) | 1 | 2016 | 5 | 0.030 |
Why?
| | Models, Organizational | 1 | 1997 | 144 | 0.030 |
Why?
| | Immunization Programs | 1 | 2017 | 194 | 0.030 |
Why?
| | Citalopram | 1 | 2015 | 33 | 0.030 |
Why?
| | Medicine | 2 | 2007 | 126 | 0.030 |
Why?
| | Fluoxetine | 1 | 2015 | 57 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 284 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 587 | 0.030 |
Why?
| | Treatment Failure | 1 | 2015 | 360 | 0.030 |
Why?
| | Uncertainty | 1 | 2014 | 146 | 0.030 |
Why?
| | Probability | 1 | 2014 | 309 | 0.020 |
Why?
| | Urban Population | 1 | 1997 | 502 | 0.020 |
Why?
| | American Recovery and Reinvestment Act | 1 | 2013 | 6 | 0.020 |
Why?
| | Reoperation | 1 | 2016 | 644 | 0.020 |
Why?
| | Insurance Claim Review | 1 | 2013 | 86 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 2017 | 541 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1046 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 852 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2014 | 225 | 0.020 |
Why?
| | Schools, Pharmacy | 1 | 2012 | 48 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 78 | 0.020 |
Why?
| | Databases as Topic | 1 | 2011 | 71 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1999 | 928 | 0.020 |
Why?
| | Models, Economic | 1 | 2012 | 64 | 0.020 |
Why?
| | Faculty | 1 | 2012 | 151 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 210 | 0.020 |
Why?
| | Health Care Rationing | 1 | 2011 | 56 | 0.020 |
Why?
| | Propensity Score | 1 | 2011 | 379 | 0.020 |
Why?
| | Patient Discharge | 1 | 2016 | 1002 | 0.020 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 162 | 0.020 |
Why?
| | Legislation, Medical | 1 | 2007 | 11 | 0.020 |
Why?
| | Poverty Areas | 1 | 2007 | 43 | 0.020 |
Why?
| | Crisis Intervention | 1 | 2007 | 37 | 0.020 |
Why?
| | Computer Simulation | 1 | 2012 | 1018 | 0.020 |
Why?
| | Appointments and Schedules | 1 | 2007 | 97 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2006 | 73 | 0.010 |
Why?
| | Ontario | 1 | 2006 | 91 | 0.010 |
Why?
| | Students | 1 | 2012 | 659 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2420 | 0.010 |
Why?
| | Osteoporosis | 1 | 2009 | 239 | 0.010 |
Why?
| | Health Status Indicators | 1 | 2006 | 168 | 0.010 |
Why?
| | Time Factors | 1 | 2016 | 7173 | 0.010 |
Why?
| | Seasons | 1 | 2007 | 540 | 0.010 |
Why?
| | Drug Monitoring | 1 | 2007 | 402 | 0.010 |
Why?
| | Pandemics | 1 | 2011 | 1720 | 0.010 |
Why?
| | Physician Incentive Plans | 1 | 2000 | 8 | 0.010 |
Why?
| | Cost Control | 1 | 2000 | 38 | 0.010 |
Why?
| | Adolescent Health Services | 1 | 2001 | 74 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2005 | 1043 | 0.010 |
Why?
| | Multicenter Studies as Topic | 1 | 2002 | 417 | 0.010 |
Why?
| | Workplace | 1 | 2002 | 272 | 0.010 |
Why?
| | Health Care Reform | 1 | 2000 | 109 | 0.010 |
Why?
| | Primary Prevention | 1 | 2000 | 228 | 0.010 |
Why?
| | Interpersonal Relations | 1 | 2002 | 403 | 0.010 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 1999 | 77 | 0.010 |
Why?
| | Quality Indicators, Health Care | 1 | 2000 | 337 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 5478 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 1999 | 338 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 779 | 0.010 |
Why?
| | Patient Care Team | 1 | 2002 | 712 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2002 | 1777 | 0.010 |
Why?
| | Prognosis | 1 | 1999 | 4384 | 0.000 |
Why?
|
|
Libby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|